CD19 and neoplasm: To investigate the potential impact of melatonin on tumor cell cytotoxicity and the expansion of chimeric antigen receptor CAR-T cells, we used a CD19-CAR construct incorporating 4-1BB co-stimulation (CD19scFv-4-1BB-CD3ζ, as depicted in Fig. 3A).